Share This Author
Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia
Characteristics of 34 adults with psychogenic excoriation.
- L. Arnold, S. McElroy, D. Mutasim, M. Dwight, C. Lamerson, E. M. Morris
- Psychology, MedicineThe Journal of clinical psychiatry
- 15 October 1998
Psychogenic excoriation is chronic, involves multiple sites, and is associated with a high rate of psychiatric comorbidity, and spans a compulsive-impulsive spectrum.
Skin manifestations of inflammatory bowel disease.
Paraneoplastic pemphigus is a newly recognized disease that occurs in some patients with lymphoproliferative neoplasms and occasionally, solid tumors that shares clinical and histologic features with erythema multiforme, toxic epidermal necrolysis, and pemPHigus vulgaris.
An open clinical trial of fluvoxamine treatment of psychogenic excoriation.
- L. Arnold, D. Mutasim, M. Dwight, C. Lamerson, E. M. Morris, S. McElroy
- PsychologyJournal of clinical psychopharmacology
- 1 February 1999
It is suggested that fluvoxamine may be effective in reducing psychogenic excoriation, and this effect seems to be independent of mood.
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
- R. Labib, G. Anhalt, H. Patel, D. Mutasim, L. Diaz
- Medicine, BiologyJournal of immunology
- 15 June 1985
It is shown that BP autoantibodies react with several protein bands, as detected by immunoblotting, which remains to be determined which of these protein bands represent specific hemidesmosomal proteins and which antibody-antigen interactions are relevant to the pathogenesis of this disease.
Immunofluorescence in dermatology.
Direct immunofluorescence testing is performed on perilesional skin for patients with bullous diseases and lesional skinFor patients with connective tissue diseases and vasculitis.
Treatment strategies in mucous membrane pemphigoid
The choice of agents for treatment of MMP is based upon the sites of involvement, clinical severity, and disease progression, and systemic corticosteroids are the agents of choice for initial treatment, combined with steroid-sparing agents for long-term maintenance.